From: "Secretary, ACS Division of Chemical Health and Safety" <secretary**At_Symbol_Here**DCHAS.ORG>
Subject: [DCHAS-L] do preclinical drugs require SDS?
Date: Wed, 6 Jan 2016 13:37:47 -0500
Reply-To: DCHAS-L <DCHAS-L**At_Symbol_Here**MED.CORNELL.EDU>
Message-ID: DC9BFAD9-53C5-4FA7-8F9B-4138A5B0E98D**At_Symbol_Here**

From: Mary Biersack <Mary.Biersack**At_Symbol_Here**>?
Re: do preclinical drugs require SDS?

Our company tests a lot of drug products from other companies for container integrity/leachables.  Does anyone know if these outside companies are required to send/have an SDS for these preclinical drug products?  I was told that all clinical phase I or higher drug products are required to have SDS if they are going to be shipped (DOT) but what about drug products in the preclinical stage?  I appreciate any guidance on this.


Mary Biersack
Lab Safety and Chemical Hygiene Specialist
West Pharmaceutical Services, Inc.
P: +1 610-594-3278
530 Herman O. West Drive | Exton, PA 19341 | United States

Previous post   |  Top of Page   |   Next post

The content of this page reflects the personal opinion(s) of the author(s) only, not the American Chemical Society, ILPI, Safety Emporium, or any other party. Use of any information on this page is at the reader's own risk. Unauthorized reproduction of these materials is prohibited. Send questions/comments about the archive to
The maintenance and hosting of the DCHAS-L archive is provided through the generous support of Safety Emporium.